Philip Morris
Fields
- Type
- COLL, COLLAGE
- Master ID
- 2031367501/7509
Related Documents: - Document File
- 2031367500/2031367509a/P0622 Smoking Cessation Act
- Litigation
- Stmn/Produced
- Site
- R530
- Area
- CARCHMAN,RICHARD
- Date Loaded
- 02 Apr 1999
- UCSF Legacy ID
- fwt77e00
Document Images
I
!
B33b LM435 P322
GOLD
JAMA-J AM MED ASSOC
broadcast antismoking commercials, smoking restrictions in show -7hy new brands pose a serious and
special danger to pub-
restaurants and private workplaces, the radio and tPh °' th over and above currently existing
brands.
ad ban, and the tar/nicotine listing requirei true that the empirical data to support a ban on
radio and television ad ban resulted in about .e advertising are equivocal. However, given the vast
in real ad spending for cigarette companies wit _
reduction in demand.3 To be prudent, a total au uan s-fiould be
accompanied by controls on the introduction of new cigarette
brands/varieties and by antismoking policies known to reduce
consumption.
Such effective measures include excise tax increases, res-
taurant smoking restrictions, and broadcasting antismoking
commercials. For each 10% increase in real cigarette price, a
demand decrease of approximately 3.7% results 3 For each
10% increase in the smoking-age population covered by gov-
ernment smoking restrictions, a drop in demand of around
6.5% is seen.3 An optimal antismoking agenda would give
highest priority to these efficacious policies.
William L. Simonich, PhD
Cancer Treatment Centers of America
Zion, Ill
1. Gostin LO, Brandt AM. Criteria for evaluating a ban on the advertisement of ctig-
arettes: balancing public health benefits with constitutional burdens. JAMA 1993;
269:904-909.
2. Bergler R. Advertising and Cigarette &rnoking: A Psychological Study. Bern,
Switzerland: Hans Huber Publishers; 1981.
3. Simonich WL. Government Antismoking Policies. New York, NY: Peter Lang
Publishing Inc; 1991.
In Reply.-Smoking is a highly complex and insufficiently
understood behavior. Consequently, effective reductions in
smoking behavior are likely to be achieved through a com-
prehensive public health strategy based on the best available
^
data. At the same time, antismoking policiPQ
spectful of human rights and ^-' '
socially Dr Sirr
could sha
manufact
elasticity,
maintain i
We supl
cigarette s
smoking pi
caution reg
Simonich-,
ban on the i
GovernmE
broad specti
public health
in public are
enacted, mon
strictions coul
Most data on s
ing long-term t
complexity of designing studies that show a causal relation-
ship between advertising and smoking, any evaluation of a
ban must rest on a careful assessment of many factors. The
profound harms of smoking, the history of unsuccessful reg-
ulation of the industry, the unique characteristics of ciga-
rettes in American life, and the minimum burdens on First
Amendment values lead us to reiterate our conclusion that a
ban on cigarette advertising would be an important part of a
comprehensive public health strategy.
Lawrence 0. Gostin, JD
American Society of Law, Medicine, and Ethics
Boston, Mass
Allan M. Brandt, PhD
Harvard Medical School
Boston, Mass
1. Respiratory Health Effects of Paesive Smoking: Lung Cancer and Other Disor-
ders. US Environmental Protection Agency, Office for Research and Development,
Office of Health and Environmental Assessment; 1992.
Nicotine Inhaler for Smoking Cessation
To the Editor.-In a recent article, Tannesen et al' suggest
that a nicotine inhaler in smoking cessation could be imple-
mented in general practitioner offices with high success rates
and that it would be "acceptable" to patients. In addition, the
program is described as "low intervention." Results from
their study do not. --- tatements.
vho were recruited through
io were motivated to quit
me to the clinic for a total
ach visit lasting "from 30
~tapes on smoking cessa-
the use of the nicotine
I and biological parame-
ing. Such broad and ex-
, but in my practice as
,iysicians, I don't think
-vention efforts. More-
:h efforts, the placebo
mg cessation rate at 1
a,2 23%'0 of participants
andomized to placebo
be acceptable to pa-
riences with the use
is been unacceptable
ine inhaler, when it
..., . ost as much or more
..~,~ used at a per-unit dose? Furthermore,
~^t
rs"o K, I
&essa.4a--L-
to smoke.' For _-- .,w, on smoking
would require -_...,.a,nent of both its public health
benefits as well as its potential intrusiveness. Policies, such
as an ad ban, that focus attention and responsibility squarely
on the tobacco industry for the risks of their product may
have certain benefits over policies directed at individual
smokers.
The proposal to ban the introduction of new cigarette brands
is also problematic. While government could constitutionally
ban the manufacture of cigarettes, it has chosen not to do so. If
government continued to allow the manufacture of cigarettes
but prohibited the introduction of new brands, it probably
would be regarded as arbitrary and capricious. In order for such
a law to pass constitutional muster, advocates would have to
322 JAMA, July 21, 1993-Vol 270, No. 3
.,,u tne patients in the study receive their inhalers free of
charge? If both answers are yes, then I expect that the
inhaler will be less acceptable than envisioned, thus making
success rates less than reported. Effectiveness trials with
other nicotine replacement strategies have shown them to be
less successful than that reported in controlled research
reports s
Finally, did patients truly use an average of 3.8 inhalers
per day, with each inhaler on average good for 300 puffs, as
reported? If true, then the average patient puffed 1.2 per
minute every hour for 16 hours a day. Again, I am not sure
my patients would find this acceptable.
Adam Goldstein, MD
University of North Carolina
Chapel Hill
A
COrGHT MERRMFDICAL ASSDC3
IL
2031367501
Letters
